BioSpace News Archive

Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company focused on developing novel drugs for inflammation, fibrosis and oncology, announced the results of its multinational Phase 2a clinical study (NCT 04596293) to evaluate the safety and efficacy of orally administered BBT-401 in subjects with active ulcerative colitis (UC).

RVAC Medicines Pte. Ltd., a messenger RNA technology platform company, announced that it has secured the approval from the Health Sciences Authority to initiate Phase 1B clinical trial in Singapore to evaluate the safety and immunogenicity of three COVID-19 mRNA vaccine candidates.

Covalon Technologies Ltd. announced its participation for the first time in the Conference for Neonatology in Las Vegas, Nevada from Wednesday, February 22 to Friday, February 24, 2023.

Antech Diagnostics, North America’s largest network of veterinary diagnostic reference laboratories, today announced that KeyScreen™ GI Parasite PCR will detect a new mutation for treatment-resistant canine hookworm by mid-April.

MedMira Inc. announces the singing of a multinational distribution agreement with Maternova, Inc., Rhode Island, USA.

Shanghai Junshi Biosciences Co., Ltd announced that the pre-specified interim analysis has been completed for a randomized, double-blind, placebo-controlled, multi-center phase III clinical study examining the company’s product toripalimab in combination with paclitaxel for injection in patients with an initial diagnosis of stage IV or recurrent/metastatic triple-negative breast cancer.